Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London. As one of the largest independent clinical research organisations in the UK, Richmond Pharmacology has the expertise and equipment to adapt its London Bridge facility to administer vaccines for many residents in Southwark and the surrounding areas.  


Neil Coyle MP for Southwark and Old Borough outlines why this is important in his interview with BBC Politics London.


Richmond Pharmacology has been supporting the local community throughout the pandemic by providing rapid COVID tests to a local primary school, church, and synagogue. Assistance was also offered to staff at nearby businesses and hospitals when testing for the virus was not easily accessible.


Keith Berelowitz, Director of Operations at Richmond Pharmacology, said: “At what could be a pivotal moment during this pandemic, we must all do what we can to expedite the rollout of the vaccine in our local communities. We recognise that Richmond Pharmacology has the skills and facilities to support the Government in ensuring that the most vulnerable in our society are protected as soon as possible.”


Latest news

Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology

December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event